PHOSPHODIESTERASE INHIBITORS - NEW OPPORTUNITIES FOR THE TREATMENT OF ASTHMA

被引:377
作者
TORPHY, TJ [1 ]
UNDEM, BJ [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DIV CLIN IMMUNOL, BALTIMORE, MD 21224 USA
关键词
D O I
10.1136/thx.46.7.512
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:512 / 523
页数:12
相关论文
共 120 条
[1]  
APPLEMAN MM, 1982, HDB EXPT PHARM, V58, P262
[2]  
AVERILL LE, 1985, CLIN RES, V33, pA839
[3]   ENDOGENOUS CATECHOLAMINES AND ASTHMA [J].
BARNES, PJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (06) :791-795
[4]  
BEAVO JA, 1970, J BIOL CHEM, V245, P5649
[5]  
BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1
[6]   PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].
BEAVO, JA ;
REIFSNYDER, DH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155
[7]  
BERGSTRAND H, 1978, MOL CELL BIOCHEM, V21, P9
[8]  
BERGSTRAND H, 1980, EUR J RESPIR DIS, V61, P37
[9]  
BEUME R, 1987, ARCH PHARM S, V335, pR76
[10]  
BEWLEY JS, 1988, BRIT J PHARMACOL, V93, pP52